1Harris E D Jr.Rheumatoid arthritis,pathophysiology and implications for therapy[J].N Engl J Med,1990,322(18):1277-1289.
2Panayi G S,Lanchbury J S,kingesley G H.The importance of the T cells in initiating and maintaining the chronic synovitis of rhermatoid arthritis[J].Arthritis Rheum,1992,35(7):729-735.
3Kurosaka M,Zitff M.Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium[J].J Exp Med,1983,158(4):1191-1210.
4Buch M H,Vital E M,Emery P.Abatacept in the treatment of rheumatoid arthritis[J].Arthritis Res Ther,2008,10(s1):S5.
5Westhovens R,Verschueren P.Translating co-stimulation blockade into clinical practice[J].Arthritis Res,Ther,2008,10(s 1):S4.
6Namekawa T,Snyder M R,Yen J H,et al.Killer cell activating receptors function as constimulatory molecules on CD4+CD28 null T cells clonally expanded in rheumatoid arthritis[J].J Immunol,2000,165(2):1138-1145.
7Goronzy J J,Henel G Sawai H,et al.Costimulatony pathways in rhermatoid synovitis and T-cell senescence[J].Ann N Y Acad Sci,2005,1062:189-194.
8Smolen J S.Aletaha D,Koeller M,et al.New therapies for treatment of rheumatoid arthritis[J].Lancet,2007,370(9802):1861-1874.
9Kremer J M,Westhovens R,Leon M,et al.Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig[J].N Engl J Med,2003,349(20):1907-1915.
10Kremer J M,Dougados M,Emery P,et al.Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept:twelve-month results of a phase lib double-blind,randomized,placebo-controlled trial[J].Arthritis Rheum,2005 52(8):2263-2271.
